MET and hepatocellular carcinoma: Although over-expression of c-Met was found to be involved in aggressive liver tumors and associated with poor prognosis in HCC [4], [5], [11], a contradictory deficiency of c-Met in hepatocytes has been reported to initiate tumorigenesis in liver [12].